WCM
ABMD

Weld Capital Management’s Abiomed Inc ABMD Stock Holding History

Weld Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,570
Closed -$509K – 615
2020
Q4 		$509K Buy
+1,570
New +$434K 0.2% 177
2020
Q1 		– Sell
-4,762
Closed -$812K – 782
2019
Q4 		$812K Buy
4,762
+1,550
+48% +$287K 0.16% 226
2019
Q3 		$571K Sell
3,212
-3,632
-53% -$785K 0.1% 337
2019
Q2 		$1.78M Buy
+6,844
New +$1.82M 0.33% 59
2019
Q1 		– Sell
-1,010
Closed -$328K – 941
2018
Q4 		$328K Buy
+1,010
New +$351K 0.07% 471

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Weld Capital Management's ABMD Position: Q1 2021 in Review

Weld Capital Management sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 1,570 shares — an estimated $509K sold.

Weld Capital Management first reported a position in ABMD in Q4 2018 and held it in 5 quarters. The position peaked at $1.78M in Q2 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Weld Capital Management reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 1,570 Abiomed Inc shares in Q1 2021, an estimated $509K.
  • Weld Capital Management first reported a position in Abiomed Inc in Q4 2018 and held it in 5 quarters.
  • Weld Capital Management's Abiomed Inc position peaked at $1.78M in Q2 2019.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.